Expanded Access Program of the PLK1 Inhibitor Onvansertib for Treatment of Patients with KRAS-mutant Metastatic Colorectal Cancer
Cancer Research（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined